Chk2 Inhibitor II-10mg and 2 more items

Cayman Chemical Company Inc was awarded a purchase order (PO-0448213) by the University of Virginia on June 12, 2026, for the supply of specialized chemical compounds. The contract, valued at $541, encompasses three distinct line items for delivery to Saainikedhana Venugopal at the University of Virginia in Virginia. The awarded items include one unit of Chk2 Inhibitor II at 10 milligrams ($132 unit price), three units of GSK1016790A at 5 milligrams ($95 per unit), and one unit of PD-1/PD-L1 Inhibitor 1 at 5 milligrams ($124 unit price).

The contract represents a procurement of research-grade chemical compounds, consistent with academic and scientific research applications. As a prime contractor award to Cayman Chemical Company Inc, this purchase order reflects the University of Virginia's acquisition of specialized inhibitor compounds utilized in pharmaceutical and biochemical research. The cumulative contract value of $541 reflects a modest procurement of specialized materials, typical of targeted research supply purchases by higher education institutions.